Glutamate and Multiple Sclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|9|1295-1299

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.9, 2012-03, pp. : 1295-1299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Response to Mousavizadeh et al.: Oxidative toxicity and glutamate excitotoxicity in multiple sclerosis

By Neuhaus O.   Kieseier B.C.   Archelos J.J.   Hartung H.-P.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 11, 2003-11 ,pp. : 564-565

Elsevier

Access to resources Recommend Favorite

Natalizumab: multiple benefits in multiple sclerosis

By  

Inpharma, Vol. 1, Iss. 1487, 2005-01 ,pp. : 9-11

Adis International

Access to resources Recommend Favorite

Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis

By Corona Juan C   Tovar-y-Romo Luis B   Tapia Ricardo  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 11, 2007-11 ,pp. : 1415-1428

Informa Healthcare

Access to resources Recommend Favorite

Role of Cannabinoids in Multiple Sclerosis

By Zajicek John P.  

CNS Drugs, Vol. 25, Iss. 3, 2011-03 ,pp. : 187-201

Adis International

Access to resources Recommend Favorite

Management of Children with Multiple Sclerosis

By Yeh E. Ann  

Pediatric Drugs, Vol. 14, Iss. 3, 2012-06 ,pp. : 165-177

Adis International

Access to resources Recommend Favorite